Private Placement Some interesting conversations surrounding this development that seem to miss the point of the PP in the first place.
The company needs more operating cash and it's not a public offering. So while investment dealers or institutional investors might not jump at this (the argument that the sp is currently at $.03 so why pay more seems a good one) does it not then suggest only insiders purchasing these shares (the argument by some that they are the ones who will do so).
Insiders clearly have a vested interest, as a consequence of their previous insider purchases, to get the sp to at least $.10. As a consequence and out of necessity they may have no other recourse but to invest at an initial loss while assuming they can "right" the proverbial financial ship and see a positive return in the not too distant future.
As for AddBio, there seems a flicker of possibility as suggested in the MD&A ....but I wouldn't hold my breath on this one .....yet!!!